Waters
Waters Q4 Revenues Rise 6 Percent
The company's Q4 revenues were $872.7 million versus $819.5 million in Q4 2023 and above the consensus Wall Street estimate of $856.9 million.
The controls are meant to restrict the access of certain countries — most notably China — to mass spec technology the government said could be put to military use.
US Government Places Export Controls on LC-MS Instruments for Top-Down Proteomics
The government did not specify which platforms would be covered by the rule but said countries are using LCMS technology to develop military capabilities.
JP Morgan Healthcare Conference, Day 1: Oxford Nanopore, 10x Genomics, Bruker, Qiagen, More
Highlights from the first day included Exact Sciences' plan to launch three new cancer tests in 2025 and Qiagen's sample prep launch plans for 2026.
Sapio Sciences, Waters Ink Comarketing Agreement for LIMS, LC-MS Software
The companies will co-market Sapio's lab information management system (LIMS) software with Waters' waters_connect software for LC/MS-based quantitation.